                         SEQUENCE LISTING

<110>  Affiris AG
 
<120>  Vaccine

<130>  R 67027

<150>  EP 14157221.4
<151>  2014-02-28

<160>  46    

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is an amino acid residue selected from the group of uncharged
       amino acid residues, preferably selected from the group 
       consisting of serine, threonine, valine and alanine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is an amino acid residue selected from the group of uncharged
       amino acid residues, preferably selected from the group of 
       isoleucine, valine, glycine, glutamine and alanine, more 
       preferably isoleucine, valine, glutamine and alanine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an amino acid residue selected from the group of uncharged
       amino acid residues, preferably selected from the group 
       consisting of proline, threonine, alanine and valine, more 
       preferably proline

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is an amino acid residue selected from the group consisting 
       of asparagine, serine, alanine, glutamine and aspartic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is an amino acid residue selected from the group consisting 
       of leucine, glycine, alanine, tyrosine, aspartic acid, 
       phe-nylalanine and valine, preferably leucine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is an amino acid residue selected from the group of 
       hy-drophilic, negatively charged amino acid residue, preferably 
       an amino acid residue selected from the group consisting of 
       glutamic acid and aspartic acid

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is an amino acid residue selected from the group of uncharged
       amino acid residues, preferably selected from the group 
       consisting of isoleucine, leucine, alanine and threonine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is an amino acid residue selected from the group of uncharged
       amino acid residues, preferably selected from the group 
       consisting of threonine, leucine, glutamine, alanine and serine 
       or nil

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is X10X11X12 as defined in the patent application as filed or
       a C-terminal truncated fragment thereof consisting of 1 or 2 
       amino acid residues or nil

<400>  1

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PCSK9 fragment

<400>  2

Ala Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence

<400>  3

Pro Ala Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence

<400>  4

Pro Glu Glu Asp Gly Thr Arg Phe Ala Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  5

Pro Glu Glu Asp Gly Thr Arg Phe His Ala Gln Ala Ser Lys 
1               5                   10                  


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  6

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Ala Ala Ser Lys 
1               5                   10                  


<210>  7
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  7

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ala Lys 
1               5                   10                  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  8

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Ala 
1               5                   10                  


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  9

Thr Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  10

Pro Gln Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  11

Pro Lys Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  12

Pro Glu Glu Asp Gly Ser Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  13
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  13

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  14
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  14

Pro Glu Glu Asp Gly Thr Arg Phe His Lys Gln Ala Ser Lys 
1               5                   10                  


<210>  15
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  15

Pro Glu Glu Asp Gly Thr Arg Phe His Met Gln Ala Ser Lys 
1               5                   10                  


<210>  16
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  16

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Glu Ala Ser Lys 
1               5                   10                  


<210>  17
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  17

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Arg Ala Ser Lys 
1               5                   10                  


<210>  18
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  18

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Lys Ala Ser Lys 
1               5                   10                  


<210>  19
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  19

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ser Ser Lys 
1               5                   10                  


<210>  20
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  20

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Thr Lys 
1               5                   10                  


<210>  21
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  21

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Asn Lys 
1               5                   10                  


<210>  22
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  22

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Leu Lys 
1               5                   10                  


<210>  23
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  23

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Arg 
1               5                   10                  


<210>  24
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  24

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Leu 
1               5                   10                  


<210>  25
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  25

Lys Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  26
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  26

Pro Glu Trp Asp Gly Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  27
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  27

Pro Glu Glu Asp Lys Thr Arg Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  28
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  28

Pro Glu Glu Asp Gly Thr Gly Phe His Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  29
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  29

Pro Glu Glu Asp Gly Thr Arg Phe Ser Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  30
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  30

Pro Glu Glu Asp Gly Thr Arg Phe Thr Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  31
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  31

Pro Glu Glu Asp Gly Thr Arg Phe Val Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  32
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  32

Pro Glu Glu Asp Gly Thr Arg Phe Gly Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  33
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  33

Pro Glu Glu Asp Gly Thr Arg Phe Met Arg Gln Ala Ser Lys 
1               5                   10                  


<210>  34
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  34

Pro Glu Glu Asp Gly Thr Arg Phe His Pro Gln Ala Ser Lys 
1               5                   10                  


<210>  35
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  35

Pro Glu Glu Asp Gly Thr Arg Phe His Ser Gln Ala Ser Lys 
1               5                   10                  


<210>  36
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  36

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Thr Ala Ser Lys 
1               5                   10                  


<210>  37
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  37

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Thr Ser Lys 
1               5                   10                  


<210>  38
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  38

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Ser 
1               5                   10                  


<210>  39
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  39

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Thr 
1               5                   10                  


<210>  40
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  40

Pro Glu Glu Asp Gly Thr Arg Phe His Arg Gln Ala Ser Val 
1               5                   10                  


<210>  41
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  41

Pro Glu Glu Asp Gly Ser Arg Phe His Lys Gln Ala Ser Lys 
1               5                   10                  


<210>  42
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  42

Pro Glu Glu Asp Gly Ser Arg Phe His Met Gln Ala Ser Lys 
1               5                   10                  


<210>  43
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  43

Pro Glu Glu Asp Gly Ser Arg Phe His Arg Arg Ala Ser Lys 
1               5                   10                  


<210>  44
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  44

Pro Glu Glu Asp Gly Ser Arg Phe His Arg Gln Ala Thr Lys 
1               5                   10                  


<210>  45
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial Sequence, Mimotope

<400>  45

Pro Glu Glu Asp Gly Ser Arg Phe His Arg Gln Ala Thr Lys 
1               5                   10                  


<210>  46
<211>  14
<212>  PRT
<213>  artificial

<220>
<223>  generic immunogenic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)

<220>
<221>  MISC_FEATURE
<222>  (9)..(14)

<400>  46

Xaa Xaa Glu Asp Gly Xaa Arg Phe Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  


